Loading...
STAAR Surgical Company
STAA•NASDAQ
Healthcare
Medical - Instruments & Supplies
$19.20
$0.22(1.16%)
STAAR Surgical Company (STAA) Financial Performance & Income Statement Overview
Review STAAR Surgical Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-2.64%
↓ 2.64%
Operating Income Growth
-144.88%
↓ 144.88%
Net Income Growth
-194.66%
↓ 194.66%
Operating Cash Flow Growth
7.75%
↑ 7.75%
Operating Margin
-24.26%
↓ 24.26%
Gross Margin
74.00%
↑ 74.00%
Net Profit Margin
-25.46%
↓ 25.46%
ROE
-17.94%
↓ 17.94%
ROIC
-17.41%
↓ 17.41%
STAAR Surgical Company (STAA) Income Statement & Financial Overview
Review STAAR Surgical Company's (STAA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $48.95M | $88.59M | $99.005M | $77.36M |
| Cost of Revenue | $17.30M | $20.10M | $20.59M | $16.32M |
| Gross Profit | $31.65M | $68.49M | $78.41M | $61.03M |
| Gross Profit Ratio | $0.65 | $0.77 | $0.79 | $0.79 |
| R&D Expenses | $12.04M | $14.50M | $14.05M | $13.38M |
| SG&A Expenses | $47.52M | $48.31M | $52.46M | $49.94M |
| Operating Expenses | $59.56M | $62.80M | $66.51M | $63.32M |
| Total Costs & Expenses | $76.86M | $82.91M | $87.11M | $79.64M |
| Interest Income | $0.00 | $0.00 | $1.42M | $1.53M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.38M | $1.76M | $1.52M | $1.24M |
| EBITDA | -$27.96M | $7.44M | $13.42M | -$1.04M |
| EBITDA Ratio | -$0.57 | $0.08 | $0.14 | -$0.01 |
| Operating Income | -$27.91M | $5.68M | $11.90M | -$2.28M |
| Operating Income Ratio | -$0.57 | $0.06 | $0.12 | -$0.03 |
| Other Income/Expenses (Net) | -$2.42M | $7.48M | -$1.56M | $70000.00 |
| Income Before Tax | -$30.33M | $13.16M | $10.33M | -$2.21M |
| Income Before Tax Ratio | -$0.62 | $0.15 | $0.10 | -$0.03 |
| Income Tax Expense | $3.89M | $3.18M | $2.96M | $1.13M |
| Net Income | -$34.23M | $9.98M | $7.38M | -$3.34M |
| Net Income Ratio | -$0.70 | $0.11 | $0.07 | -$0.04 |
| EPS | -$0.001 | $0.20 | $0.15 | -$0.07 |
| Diluted EPS | -$0.001 | $0.20 | $0.15 | -$0.07 |
| Weighted Avg Shares Outstanding | $49.27M | $49.20M | $49.13M | $48.91M |
| Weighted Avg Shares Outstanding (Diluted) | $49.27M | $49.73M | $49.81M | $48.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan